Mounjaro delivered superior and consistent A1C reductions against all of the comparators throughout the SURPASS program, which was designed to assess Mounjaro's efficacy and safety in a broad range of adults with type 2 diabetes who could be treated in clinical practice, Juan Pablo Fras, MD, medical director of the National Research Institute and a researcher involved in the SURPASS program, said in a statement
GLP-1s are overtaking other common treatments for diabetes, particularly among the commercially insured GLP-1s are reshaping treatment for T2D and causing shifts in treatment paradigms across multiple disease areas
Furthermore, hematoxylin and eosin (H&E) staining Perls staining and Masson's trichrome staining of the liver tissues revealed that iron overload induced liver injury and fibrosis (Fig
Unlike traditional PDE5 inhibitors which act on the vascular system, PT-141 is investigated for its mechanism of action within the Central Nervous System (CNS)
This combination works more powerfully on hunger, metabolism, and fat storage than GLP-1 alone
